Top Qs
Timeline
Chat
Perspective

DMBMPP

Chemical compound From Wikipedia, the free encyclopedia

DMBMPP
Remove ads

DMBMPP, or 2-(2,5-dimethoxy-4-bromobenzyl)-6-(2-methoxyphenyl)piperidine, also known as juncosamine, is a highly selective serotonin 5-HT2A receptor agonist and 2-benzylpiperidine analogue of the serotonergic psychedelic 25B-NBOMe that was discovered in 2011 by Jose Juncosa in the group of David E. Nichols at Purdue University.[1][2] It differs from 25B-NBOMe by incorporating the amine within a piperidine ring, making for a more rigid molecular structure than that of the open-chain 25B-NBOMe. The presence of the piperidine ring introduces two stereocenters, thus, four stereoisomers of this compound can be made.

Quick Facts Clinical data, Other names ...
Remove ads

Despite its uniquely high selectivity for the serotonin 5-HT2A receptor, it has been said that DMBMPP is not widely used as a pharmacological tool in scientific research, presumably due to its chemical synthesis being relatively inaccessible.[3] Consequently, 25CN-NBOH, another highly selective serotonin 5-HT2A receptor agonist, has been proposed as an alternative to DMBMPP for use in scientific research.[3]

Remove ads

Pharmacology

The (S,S)-isomer ((2S,6S)-DMBMPP) is the most selective agonist for the human serotonin 5-HT2A receptor yet discovered, with a Ki of 2.5 nM at the human 5-HT2A receptor and with 124-fold selectivity for the serotonin 5-HT2A receptor over the structurally similar serotonin 5-HT2C receptor.[2] Together with 25CN-NBOH,[4] (2S,6S)-DMBMPP is the only known 5-HT2A agonist to exhibit this level of selectivity.[3]

More information Ligand, Ki ± SEM (nM) ...
Remove ads

See also

References

Loading related searches...

Wikiwand - on

Seamless Wikipedia browsing. On steroids.

Remove ads